| Variation name (cDNA level) | Variation name (protein level) | Variation status |
| c.IVS10-9G>A (c.1662-9G>A) |
| wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
| AGC | Ser | spl-9 | Spl. | G>A |
| Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
| EXO1 stabilization |
| At the mRNA level | On restriction map |
| New restriction site(s): none Lost restriction site(s): none |
| Impact on splicing | ||||||||||
| Splice site type | Wild type sequence | CV | Mutant type sequence | CV | Variation (%) | |||||
| ttcgatttgcagCA |
| ttcaatttgcagCA |
| -0.1 % | ||||||
| Sample ID | Patient status |
| 2_02-DDM6993_27261_27261 | Relative |
| Symptom |
| Reference ID | Reference |
| 2 | Unpublished data |